)
Safe by Design: Unbiased Tools for CRISPR Safety in Cell and Gene Therapy
- How our understanding of gene-editing–related side effects has evolved
- An overview of available safety assessment techniques, including their strengths and limitations
- Strategies for harmonising safety data to clarify expectations for preclinical and clinical development packages in cell and gene therapy
